Septerna Inc. shares soared as much as 42% in their trading debut after the biotechnology company raised $288 million in an enlarged initial public offering.
The South San Francisco-based firm’s shares traded at $25.50 each at 12:15 p.m. on Friday in New York, above the IPO price of $18 apiece. The company had increased the size of the stock sale twice and sold 16 million shares on Thursday at a price above an initially marketed range.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.